These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8395940)

  • 1. Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility.
    Iles DE; Segers B; Sengers RC; Monsieurs K; Heytens L; Halsall PJ; Hopkins PM; Ellis FR; Hall-Curran JL; Stewart AD
    Hum Mol Genet; 1993 Jul; 2(7):863-8. PubMed ID: 8395940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect.
    Sudbrak R; Golla A; Hogan K; Powers P; Gregg R; Du Chesne I; Lehmann-Horn F; Deufel T
    Hum Mol Genet; 1993 Jul; 2(7):857-62. PubMed ID: 8395939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.
    Iles DE; Lehmann-Horn F; Scherer SW; Tsui LC; Olde Weghuis D; Suijkerbuijk RF; Heytens L; Mikala G; Schwartz A; Ellis FR
    Hum Mol Genet; 1994 Jun; 3(6):969-75. PubMed ID: 7951247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution physical mapping of four microsatellite repeat markers near the RYR1 locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families.
    Iles DE; Segers B; Heytens L; Sengers RC; Wieringa B
    Genomics; 1992 Nov; 14(3):749-54. PubMed ID: 1427902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
    Steinfath M; Scholz J; Singh S; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.
    Monnier N; Procaccio V; Stieglitz P; Lunardi J
    Am J Hum Genet; 1997 Jun; 60(6):1316-25. PubMed ID: 9199552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q.
    Levitt RC; Olckers A; Meyers S; Fletcher JE; Rosenberg H; Isaacs H; Meyers DA
    Genomics; 1992 Nov; 14(3):562-6. PubMed ID: 1427885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the gamma-subunit of the skeletal muscle L-type voltage-dependent calcium channel gene (CACNLG) to human chromosome band 17q24 by in situ hybridization and identification of a polymorphic repetitive DNA sequence at the gene locus.
    Iles DE; Segers B; Weghuis DO; Suikerbuijk R; Wieringa B
    Cytogenet Cell Genet; 1993; 64(3-4):227-30. PubMed ID: 8404045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1.
    Sudbrak R; Procaccio V; Klausnitzer M; Curran JL; Monsieurs K; van Broeckhoven C; Ellis R; Heyetens L; Hartung EJ; Kozak-Ribbens G
    Am J Hum Genet; 1995 Mar; 56(3):684-91. PubMed ID: 7887423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees.
    Robinson RL; Monnier N; Wolz W; Jung M; Reis A; Nuernberg G; Curran JL; Monsieurs K; Stieglitz P; Heytens L; Fricker R; van Broeckhoven C; Deufel T; Hopkins PM; Lunardi J; Mueller CR
    Hum Mol Genet; 1997 Jun; 6(6):953-61. PubMed ID: 9175745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.
    Quane KA; Keating KE; Manning BM; Healy JM; Monsieurs K; Heffron JJ; Lehane M; Heytens L; Krivosic-Horber R; Adnet P
    Hum Mol Genet; 1994 Mar; 3(3):471-6. PubMed ID: 8012359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility.
    Deufel T; Golla A; Iles D; Meindl A; Meitinger T; Schindelhauer D; DeVries A; Pongratz D; MacLennan DH; Johnson KJ
    Am J Hum Genet; 1992 Jun; 50(6):1151-61. PubMed ID: 1598899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia--a large kindred linked to the RYR1 gene.
    Wallace AJ; Wooldridge W; Kingston HM; Harrison MJ; Ellis FR; Ford PM
    Anaesthesia; 1996 Jan; 51(1):16-23. PubMed ID: 8669559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
    Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
    J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia.
    O'Brien RO; Taske NL; Hansbro PM; Matthaei KI; Hogan SP; Denborough MA; Foster PS
    J Med Genet; 1995 Nov; 32(11):913-4. PubMed ID: 8592342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of the gene encoding the gamma subunit of the human skeletal muscle 1,4-dihydropyridine-sensitive Ca2+ channel (CACNLG), cDNA sequence, gene structure, and chromosomal location.
    Powers PA; Liu S; Hogan K; Gregg RG
    J Biol Chem; 1993 May; 268(13):9275-9. PubMed ID: 8387489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees.
    Keating KE; Quane KA; Manning BM; Lehane M; Hartung E; Censier K; Urwyler A; Klausnitzer M; Muller CR; Heffron JJ
    Hum Mol Genet; 1994 Oct; 3(10):1855-8. PubMed ID: 7849712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markers.
    Fagerlund TH; Islander G; Ranklev-Twetman E; Berg K
    Clin Genet; 1996 Dec; 50(6):455-8. PubMed ID: 9147872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of heterozygous and homozygous individuals with the novel RYR1 mutation Cys35Arg in a large kindred.
    Lynch PJ; Krivosic-Horber R; Reyford H; Monnier N; Quane K; Adnet P; Haudecoeur G; Krivosic I; McCarthy T; Lunardi J
    Anesthesiology; 1997 Mar; 86(3):620-6. PubMed ID: 9066328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
    Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV
    Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.